P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast

被引:56
作者
Paredes, J
Milanezi, F
Viegas, L
Amendoeira, I
Schmitt, F
机构
[1] Univ Porto, Inst Pathol & Mol Immunol, P-4200 Oporto, Portugal
[2] Lusiada Fdn, Med Sci Fac Santos, Sao Paulo, Brazil
[3] Hosp Sao Joao, Dept Pathol, Oporto, Portugal
关键词
cadherins; ductal carcinoma in situ of the breast; P-cadherin; E-cadherin; cell polarity;
D O I
10.1007/s004280100487
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cadherins are calcium-dependent cell-cell adhesion glycoproteins, separated into several subclasses with distinct adhesive specificities and tissue distribution, which play an important role in many cellular events. We analyse the expression of E-, N- and P-cadherin in a series of ductal carcinoma in situ (DCIS) of the breast, since this disease represents a heterogeneous group, with different risks of progression to invasive breast carcinoma. We also studied the correlation between cadherin expression and DCIS classification systems, namely the Van Nuys and the Holland et al. classification, this latter based on cytonuclear differentiation and cell polarity. Our results showed that, regardless the classification applied, P-cadherin expression is strongly associated with high histological grade of DCIS (P=0.0047) and lack of estrogen receptors (P=0.0008). The use of Holland et al. classification showed a significant correlation between P-cadherin expression and decreased cell polarity (P=0.01). In conclusion, P-cadherin expression seems to be more relevant in DCIS pathogenesis than the altered expression of any other cadherin, including the decrease of E-cadherin expression.
引用
收藏
页码:16 / 21
页数:6
相关论文
共 49 条
[1]  
Bànkfalvi A, 1999, HISTOPATHOLOGY, V34, P25
[2]  
Berx G, 1996, ONCOGENE, V13, P1919
[3]   E-cadherin is a tumour invasion suppressor gene mutated in human lobular breast cancers [J].
Berx, G ;
CletonJansen, AM ;
Nollet, F ;
deLeeuw, WJF ;
vandeVijver, MJ ;
Cornelisse, C ;
vanRoy, F .
EMBO JOURNAL, 1995, 14 (24) :6107-6115
[4]  
Bukholm IK, 1998, J PATHOL, V185, P262, DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO
[5]  
2-Y
[6]  
Bukholm IK, 2000, J PATHOL, V190, P15
[7]  
FISH EM, 1994, NEW ENGL J MED, V330, P1580
[8]  
GAMALLO C, 1993, AM J PATHOL, V142, P987
[9]  
Gonzalez MA, 1999, J PATHOL, V187, P523, DOI 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO
[10]  
2-3